Peterson Wealth Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Sell
3,253
-96
-3% -$8.04K 0.06% 113
2026
Q1
$268K Buy
3,349
+259
+8% +$21.4K 0.07% 116
2025
Q4
$263K Sell
3,090
-1,510
-33% -$124K 0.07% 106
2025
Q3
$241K Buy
4,600
+1,653
+56% +$129K 0.06% 110
2025
Q2
$230K Sell
2,947
-1,947
-40% -$145K 0.06% 111
2025
Q1
$355K Buy
4,894
+111
+2% +$7.95K 0.11% 105
2024
Q4
$354K Buy
4,783
+453
+10% +$31.7K 0.11% 102
2024
Q3
$286K Buy
4,330
+708
+20% +$51.4K 0.09% 106
2024
Q2
$335K Buy
3,622
+46
+1% +$4.07K 0.12% 101
2024
Q1
$342K Buy
3,576
+448
+14% +$37.6K 0.12% 101
2023
Q4
$239K Sell
3,128
-330
-10% -$23K 0.1% 89
2023
Q3
$240K Buy
3,458
+27
+0.8% +$2.17K 0.18% 59
2023
Q2
$324K Buy
3,431
+59
+2% +$5.13K 0.16% 73
2023
Q1
$279K Buy
3,372
+15
+0.4% +$1.18K 0.14% 76
2022
Q4
$250K Buy
3,357
+65
+2% +$5.01K 0.14% 81
2022
Q3
$272K Buy
3,292
+299
+10% +$28.8K 0.19% 74
2022
Q2
$285K Buy
2,993
+140
+5% +$14.5K 0.21% 75
2022
Q1
$336K Buy
2,853
+531
+23% +$59.6K 0.21% 72
2021
Q4
$301K Buy
+2,322
New +$271K 0.2% 69

Other funds holding EW

Peterson Wealth Services's EW Position: Q2 2026 in Review

Peterson Wealth Services reduced its Edwards Lifesciences (EW) stake by 2.9% in Q2 2026, selling an estimated $8.04K and leaving 3,253 shares worth $294K. The position accounts for 0.06% of the portfolio, ranked #113.

Peterson Wealth Services first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $355K in Q1 2025. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Peterson Wealth Services held 3,253 shares of Edwards Lifesciences worth $294K as of Q2 2026.
  • Peterson Wealth Services sold 96 Edwards Lifesciences shares in Q2 2026, an estimated $8.04K.
  • Edwards Lifesciences made up 0.06% of Peterson Wealth Services's portfolio in Q2 2026, its #113 holding.
  • Peterson Wealth Services first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • Peterson Wealth Services's Edwards Lifesciences position peaked at $355K in Q1 2025.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Peterson Wealth Services's 13F filing for Q2 2026, filed 27 Jul 2026.